ATE512216T1 - Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein - Google Patents

Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein

Info

Publication number
ATE512216T1
ATE512216T1 AT02731360T AT02731360T ATE512216T1 AT E512216 T1 ATE512216 T1 AT E512216T1 AT 02731360 T AT02731360 T AT 02731360T AT 02731360 T AT02731360 T AT 02731360T AT E512216 T1 ATE512216 T1 AT E512216T1
Authority
AT
Austria
Prior art keywords
cancer
called
detection
treatment
nucleic acid
Prior art date
Application number
AT02731360T
Other languages
English (en)
Inventor
Pia Chalitta-Eid
Arthur Raitano
Mary Faris
Rene Hubert
Karen Morrison
Robert Morrison
Wangmao Ge
Aya Jakobovits
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of ATE512216T1 publication Critical patent/ATE512216T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02731360T 2001-04-10 2002-04-09 Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein ATE512216T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28273901P 2001-04-10 2001-04-10
US28663001P 2001-04-25 2001-04-25
PCT/US2002/011643 WO2002083919A2 (en) 2001-04-10 2002-04-09 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer

Publications (1)

Publication Number Publication Date
ATE512216T1 true ATE512216T1 (de) 2011-06-15

Family

ID=26961649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731360T ATE512216T1 (de) 2001-04-10 2002-04-09 Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein

Country Status (9)

Country Link
US (8) US7135549B1 (de)
EP (1) EP1573022B1 (de)
AT (1) ATE512216T1 (de)
AU (1) AU2002303340A1 (de)
CA (1) CA2443147A1 (de)
CY (1) CY1113064T1 (de)
DK (1) DK1573022T3 (de)
PT (1) PT1573022E (de)
WO (2) WO2002083860A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083860A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
JP2006515271A (ja) 2002-07-23 2006-05-25 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス グレリン類似体
WO2004072251A2 (en) * 2003-02-07 2004-08-26 Wisconsin Alumni Research Foundation Directed genetic modifications of human stem cells
CN101287748B (zh) 2005-04-20 2013-03-27 百疗医株式会社 一种融合蛋白的组成及其分离方法
US20100203553A1 (en) * 2009-02-11 2010-08-12 Abdeen Suad M Histochemical and biomarker for liver fibrosis
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
WO2012075411A1 (en) * 2010-12-03 2012-06-07 The Board Of Trustees Of The Leland Stanford Junior University Quantitative aggregation sensors
WO2013101611A1 (en) 2011-12-30 2013-07-04 Abbott Molecular Inc. Materials and methods for diagnosis of bladder cancer and monitoring recurrence thereof
WO2014055289A1 (en) 2012-10-01 2014-04-10 Thomas Jefferson University Immunization with rabies virus vector expressing foreign protein antigen
EP3039032B1 (de) * 2013-08-27 2021-05-19 The Royal Institution for the Advancement of Learning / McGill University Verfahren und zusammensetzungen zur behandlung von knorpel- und bandscheibenpathologien

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5976535A (en) * 1992-06-09 1999-11-02 Neorx Corporation Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
US5872094A (en) 1993-01-06 1999-02-16 The General Hospital Corporation Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface
WO1996009395A2 (de) 1994-09-21 1996-03-28 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Arzneimittel zur prophylaxe und behandlung von und diagnostika zur erkennung von autoimmunkrankheiten und viralen erkrankungen
CA2265889A1 (en) * 1996-09-06 1998-03-12 The Regents Of The University Of California E25a protein, methods for production and use thereof
EP1094828A4 (de) 1998-05-07 2005-01-26 Univ California Verwendung vernachlässigter gewebsspezifischer antigene zur modulation der immunantwort
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2004507202A (ja) 1999-03-31 2004-03-11 キュラジェン コーポレイション ポリペプチドをコードするオープンリーディングフレームを含む核酸;「orfx」
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
US20020119452A1 (en) 2000-01-18 2002-08-29 Phippard Deborah J. Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells
JP2003521902A (ja) 2000-01-20 2003-07-22 ユニバーシティ オブ バージニア パテント ファウンデーション 卵特異的表面タンパク質
WO2001055448A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1290217A2 (de) 2000-02-04 2003-03-12 Aeomica, Inc. Methoden und apparat zur voraussage, bestätigung und darstellung funktionaler information, abgeleitet von genomischen sequenzen
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2001088188A2 (en) 2000-05-18 2001-11-22 Nihon University, School Juridical Person Method for examining ischemic conditions
AU2002210791A1 (en) 2000-07-28 2002-02-13 Compugen Inc. Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2003010327A2 (en) 2001-02-21 2003-02-06 Curagen Corporation Novel proteins and nucleic acids encoding same
WO2002083860A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
WO2002090531A2 (en) 2001-05-03 2002-11-14 Akzo Nobel N.V. Peptidylarginine deiminase 6

Also Published As

Publication number Publication date
US7592149B2 (en) 2009-09-22
US8168187B2 (en) 2012-05-01
WO2002083919A2 (en) 2002-10-24
US20110123539A1 (en) 2011-05-26
WO2002083919A3 (en) 2007-06-28
AU2002303340A8 (en) 2007-08-30
US20110110952A1 (en) 2011-05-12
US20090264381A1 (en) 2009-10-22
CY1113064T1 (el) 2016-04-13
PT1573022E (pt) 2011-08-23
WO2002083860A2 (en) 2002-10-24
US20070054284A1 (en) 2007-03-08
US20040062761A1 (en) 2004-04-01
WO2002083860A9 (en) 2013-11-07
US7135549B1 (en) 2006-11-14
US7879570B2 (en) 2011-02-01
US20090148854A1 (en) 2009-06-11
EP1573022B1 (de) 2011-06-08
CA2443147A1 (en) 2002-10-24
US7960527B2 (en) 2011-06-14
AU2002303340A1 (en) 2002-10-28
EP1573022A2 (de) 2005-09-14
US20100168214A1 (en) 2010-07-01
EP1573022A4 (de) 2008-01-09
US7667015B2 (en) 2010-02-23
DK1573022T3 (da) 2011-09-12

Similar Documents

Publication Publication Date Title
WO2003022995A3 (en) Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
WO2003040340A3 (en) Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
WO2004016799A3 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
WO2003050255A3 (en) Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
ATE541052T1 (de) Varianten des prostata-stammzellen-antigens (psca) und teilsequenzen davon
EP2280030A3 (de) Nukleinsäuren und zugehörige Proteine für die Behandlung und den Nachweis von Krebs
CY1113064T1 (el) Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 184ρ1ε2 χρησιμα στη θεραπεια και ανιχνευση καρκινου
WO2004098515A3 (en) Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
IL181218A0 (en) Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer
ATE353366T1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
WO2002072785A3 (en) Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
WO2004067716A3 (en) Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
WO2002060953A3 (en) Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
WO2002083928A3 (en) Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
WO2006055004A8 (en) Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer
WO2002092842A3 (en) Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
WO2004050828A3 (en) Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
WO2002095009A3 (en) Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
WO2004021977A3 (en) Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
ATE415418T1 (de) Nukleinsäure und entsprechendes protein mit der bezeichnung 121p2a3 zur behandlung und zum nachweis von krebs
ATE533507T1 (de) Nukleinsäure und entsprechendes protein mit der bezeichnung 238p1b2, geeignet zur behandlung und zum nachweis von krebs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1573022

Country of ref document: EP